Washington — President Trump’s latest nominee for surgeon general, Dr. Nicole Saphier, is set to face the Senate health committee on Wednesday. The hearing marks the administration’s third effort to fill the nation’s top public‑health post, a role that, while limited in direct policymaking, provides a powerful platform to communicate health information to American families.
Why Dr. Saphier Matters for American Families
Dr. Saphier is a board‑certified radiologist and former Fox News contributor who has built a reputation for questioning blanket vaccine mandates. Like her predecessor, Dr. Casey Means, she has expressed skepticism about the necessity of giving every newborn the hepatitis B vaccine, a stance that aligns with the Trump administration’s ongoing effort to give parents more choice in medical decisions for their children.
Her medical credentials include a Doctor of Medicine degree from Ross University School of Medicine in Barbados and fellowships at the Mayo Clinic. She currently serves as director of breast imaging at Memorial Sloan Kettering Monmouth, a respected cancer‑treatment center in New York.
Potential Policy Impact
Although the surgeon general’s office does not set policy, the position carries a “loud megaphone” for shaping public opinion. Senate members are expected to probe Dr. Saphier’s views on vaccine guidance, especially as Health Secretary Robert F. Kennedy Jr. pushes to scale back certain recommendations amid rising measles cases. The Trump administration has consistently advocated for parental‑rights and limited government intrusion in health decisions, and Dr. Saphier’s record suggests she will continue that approach.
Ethics and Business Interests
In a recent ethics filing dated Sept. 7, Dr. Saphier disclosed holdings in several healthcare and consumer‑goods companies, including Coca‑Cola, Yum Brands, Hershey Co., and Philip Morris. She also listed ownership of DropRx, a firm that produces unregulated tinctures marketed for focus and calm. The filing states she will resign from DropRx and its parent company, Empower MD LLC, and will divest from any holdings that could present a conflict of interest if confirmed.
Senate Questions Expected
Senators are likely to ask about Dr. Saphier’s stance on mandatory vaccination, her relationship with the Kennedy‑led health department, and how she plans to balance public‑health messaging with respect for family autonomy. Critics from both parties have previously challenged Secretary Kennedy’s vaccine‑policy proposals, and they will probably press Dr. Saphier on whether she will support a stronger pro‑vaccination stance if confirmed.
Administration’s Perspective
President Trump’s team has emphasized that the surgeon general should serve as a trusted voice for American families, providing clear, science‑based information without overreaching government mandates. The administration views Dr. Saphier’s background in radiology and her experience communicating health issues on national media as assets that will help restore confidence in public‑health messaging.
“We need a surgeon general who respects parental rights and can speak plainly to the American people,” said a senior White House official. “Dr. Saphier’s expertise and her willingness to question one‑size‑fits‑all vaccine policies align with the President’s commitment to individual liberty and family values.”
What’s Next?
The Senate health committee will hold a closed‑door session before the public hearing, after which the full committee will vote on whether to advance Dr. Saphier’s nomination to the full Senate. If confirmed, she would join the Trump administration’s broader effort to promote health‑care choices, reduce regulatory overreach, and empower families across the nation.
Original reporting: Alexandria, VA News – WTOP News — read the source article.
